Chengdu Easton Biopharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 14.00% vs -1.02% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 25.41% vs 185.85% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "343.70",
          "val2": "301.50",
          "chgp": "14.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "81.00",
          "val2": "64.50",
          "chgp": "25.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.70",
          "chgp": "-14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.40",
          "val2": "3.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "76.00",
          "val2": "60.60",
          "chgp": "25.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "174.50%",
          "val2": "144.30%",
          "chgp": "3.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.88% vs -4.61% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.12% vs -8.07% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,328.80",
          "val2": "1,099.30",
          "chgp": "20.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "252.60",
          "val2": "228.50",
          "chgp": "10.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "3.70",
          "chgp": "5.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "14.90",
          "val2": "14.60",
          "chgp": "2.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "238.20",
          "val2": "226.60",
          "chgp": "5.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "126.50%",
          "val2": "139.90%",
          "chgp": "-1.34%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

343.70

301.50

14.00%

Operating Profit (PBDIT) excl Other Income

81.00

64.50

25.58%

Interest

0.60

0.70

-14.29%

Exceptional Items

3.40

3.40

Consolidate Net Profit

76.00

60.60

25.41%

Operating Profit Margin (Excl OI)

174.50%

144.30%

3.02%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 14.00% vs -1.02% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 25.41% vs 185.85% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,328.80

1,099.30

20.88%

Operating Profit (PBDIT) excl Other Income

252.60

228.50

10.55%

Interest

3.90

3.70

5.41%

Exceptional Items

14.90

14.60

2.05%

Consolidate Net Profit

238.20

226.60

5.12%

Operating Profit Margin (Excl OI)

126.50%

139.90%

-1.34%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 20.88% vs -4.61% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 5.12% vs -8.07% in Dec 2023

All Annual Results